• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Rx&D and Canadian government partner to strengthen research

Rx&D and Canadian government partner to strengthen research

March 21, 2012
CenterWatch Staff

Canada’s Research Based Pharmaceutical Companies (Rx&D) and the Canadian Institutes of Health Research (CIHR) have renewed a partnership to strengthen clinical research done in Canada, announced Leona Aglukkaq, Minister of Health.

“Our government is proud to support research that will deliver better treatments and better care for Canadians,” said Minister Aglukkaq. “This partnership will enhance Canada’s reputation as world-class center for clinical research and ensure new findings are applied to bedside care, for patients.”

The partnership seeks to strengthen Canada’s position as a preferred location to conduct clinical research. The partnership will play a key role in the implementation of the Strategy for Patient-Oriented Research, a national initiative to ensure better translation of research findings into clinical practice that was announced August 2011.

Through the partnership, CIHR and Rx&D member companies will fund clinical research across Canada through a competitive, peer-reviewed process and improve the coordination of research activities. Rx&D member companies have set an objective to match CIHR clinical research commitments dollar-for-dollar.

“This partnership will better integrate health research and health care,” said Dr. Alain Beaudet, president of CIHR. “By bringing together researchers and industry, this partnership will accelerate the development of new clinical practices and health products which will have a direct impact on treatment and services provided to patients.”

    Upcoming Events

    • 05Dec

      Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing